TRT 'why do it': separating real benefits from hype

What did @dt.roth actually say?

The short version: he's running what sounds like 3 IU of growth hormone and 400mg of something he calls "sasra" (almost certainly Sustanon or a testosterone blend) and framing it as his TRT protocol for health and longevity. He says "there's no numbers" for TRT, that it's based on how you feel, what your labs show, and what your "bowler" (likely "bloodwork") looks like. He also casually mentions throwing in Deca, insulin, and growth hormone in the off-season, and Trenbolone and Masteron for contest prep.

To be direct: this is not a TRT protocol. This is a bodybuilding cycle being labeled as hormone optimization. That framing matters, and it misleads viewers who are genuinely trying to understand medically supervised testosterone therapy.

Does the science back this up?

The claim that TRT has no fixed numbers is partially grounded in reality, but 400mg per week is not TRT by any clinical standard. Full stop.

Clinical TRT typically targets serum testosterone levels between 400 and 700 ng/dL, sometimes up to 1000 ng/dL in certain guidelines. Doses used in supervised medical settings to achieve that range generally fall between 50mg and 200mg per week of testosterone cypionate or enanthate, depending on the individual's metabolism and injection frequency (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). A 400mg weekly dose would push most men into supraphysiological territory, often exceeding 1500-2500 ng/dL total testosterone, levels associated with increased erythrocytosis, suppressed HDL, and cardiovascular strain over time (Coward et al., 2013, Journal of Urology). The idea that you should adjust based on labs and symptoms is legitimate medicine. Applying that logic to justify 400mg per week is not.

What did they get wrong (or right)?

He got one thing right: personalization in hormone therapy is real. The Endocrine Society's clinical practice guidelines do acknowledge that optimal testosterone levels vary between individuals and that symptom response matters alongside lab values. That part is defensible.

What he got wrong is consequential. Stacking testosterone with insulin and growth hormone is not a longevity protocol. Exogenous insulin use in non-diabetic individuals carries a real risk of hypoglycemic episodes, seizures, and death. Trenbolone is a veterinary androgen with no approved human use and a documented adverse cardiovascular and psychiatric profile (Pope et al., 2014, Drug and Alcohol Dependence). Framing any of this as "what I do for my TRT" conflates medically supervised replacement therapy with anabolic steroid cycling. These are not the same thing, and presenting them as variations on a spectrum is misleading to a 63,000-person audience.

He also offers no acknowledgment of risk. Not a word about hematocrit monitoring, cardiovascular screening, or the fact that insulin without medical supervision has killed people.

What should you actually know?

If you are being evaluated for low testosterone, here is what legitimate care looks like. A provider should confirm hypogonadism with at least two fasting morning total testosterone measurements below 300 ng/dL, along with consistent symptoms like fatigue, low libido, or loss of muscle mass (Mulhall et al., 2018, Journal of Urology). Starting doses in clinical settings are conservative, and titration is based on follow-up labs at 6 to 12 weeks, not on feel alone.

The "how you feel" component is not wrong in principle. Patient-reported outcomes are a legitimate part of hormone management. But they supplement objective data; they do not replace it. Running 400mg per week because it feels right is not medicine. It is cycling.

• Standard clinical TRT doses: 50-200mg per week of testosterone cypionate or enanthate
• Target serum levels in most guidelines: 400-700 ng/dL, with some clinicians targeting up to 1000 ng/dL
• Supraphysiological testosterone use is associated with adverse cardiovascular remodeling, polycythemia, and lipid changes
• Exogenous insulin use outside diabetes management is not a recognized anti-aging intervention and carries lethal risk
• Trenbolone has no approved human indication and should not appear in any conversation about health optimization